Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Stockholders' Equity

v3.26.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
AOCI Attributable to Parent
Accumulated Deficit
Beginning balance at Dec. 31, 2023 $ 37,784 $ 2 $ 477,624 $ (4,556) $ (435,286)
Beginning balance, shares at Dec. 31, 2023   22,604,676      
Release of Restricted Stock Units and Performance Stock Units   1,444,087      
Issuance of common stock upon ESPP purchase, shares   146,829      
Issuance of common stock upon ESPP purchase 895   895    
Exercise of stock options 335   335    
Exercise of stock options, shares   46,707      
Stock compensation expense 19,990   19,990    
Issuance of common stock under Securities Purchase Agreements, Shares   2,976,191      
Issuance of common stock under Securities Purchase Agreements 37,882 $ 1 37,881    
Net Income (Loss) (103,359)       (103,359)
Foreign currency translation adjustments (5,213)     (5,213)  
Net unrealized gain (loss) on investments (net of tax) (1)     (1)  
Ending balance at Dec. 31, 2024 (11,687) $ 3 536,725 (9,770) (538,645)
Ending balance, shares at Dec. 31, 2024   27,218,490      
Beginning balance at Dec. 31, 2024 (11,687) $ 3 536,725 (9,770) (538,645)
Beginning balance, shares at Dec. 31, 2024   27,218,490      
Release of Restricted Stock Units and Performance Stock Units   1,535,709      
Issuance of common stock upon ESPP purchase, shares   102,505      
Issuance of common stock upon ESPP purchase 807   807    
Exercise of stock options $ 1,827   1,827    
Exercise of stock options, shares 241,532 241,532      
Stock compensation expense $ 18,702   18,702    
Issuance of common stock under Securities Purchase Agreements, Shares   4,843,750      
Issuance of common stock under Securities Purchase Agreements 36,047   36,047    
Net Income (Loss) 51,305       51,305
Foreign currency translation adjustments 4,303     4,303  
Exercise of warrants, shares   673,146      
Exercise of warrants, value 11,592   11,592    
Net unrealized gain (loss) on investments (net of tax) 32     32  
Ending balance at Dec. 31, 2025 $ 112,928 $ 3 $ 605,700 $ (5,435) $ (487,340)
Ending balance, shares at Dec. 31, 2025   34,615,132